SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-18-000041
Filing Date
2018-05-07
Accepted
2018-05-07 07:05:05
Documents
4
Period of Report
2018-05-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8-kmay22018atmoffering.htm 8-K 32851
2 TG OPINION exhibit5opinion-may2018atm.htm EX-5.1 16074
3 SALES AGREEMENT a101-salesagreement.htm EX-10.1 267752
4 PRESS RELEASE may2018miritazpressrelease.htm EX-99.1 12561
  Complete submission text file 0001561743-18-000041.txt   330334
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 18809656
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1